Product Information
MORPHINE SULFATE ER 30 MG CAP is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $3.2824 per EA under NDC 00832022700. Its NADAC has been published 642 times since Nov 28, 2013.
FDA first approved this application on Jun 3, 2013.
Strength
30 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00832022700
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
3/19/2025
Active Ingredients
MORPHINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA202104FDA Approved
6/3/2013
On Market Since
6/30/2013
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE SULFATE ER 30 MG CAP has been published 642 times since Nov 28, 2013, and over the history we have for it it has declined 13.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.2824 per EA |
|---|---|
| All-time high | $4.1748 (Jul 15, 2015) |
| All-time low | $1.8067 (Oct 23, 2019) |
| 52-week high | $3.2824 |
| 52-week low | $3.2824 |
| Median price | $3.2212 |
| Average price | $3.1207 |
| Largest weekly change | +51.3% (Nov 18, 2020) |
| Weeks tracked | 642 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
0.0%
3Y
+33.6%
5Y
+16.5%
All
-13.1%
Last surveyed Mar 11, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MORPHINE SULFATE ER 30 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULFATE ER 30 MG CAP, manufactured by Upsher-Smith Laboratories LLC, is $3.2824 per EA (NDC 00832022700), effective Mar 11, 2026.
How has the price of MORPHINE SULFATE ER 30 MG CAP changed over time?
Over the history we have for it, the NADAC for MORPHINE SULFATE ER 30 MG CAP has declined 13.1%. It has been tracked across 642 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MORPHINE SULFATE ER 30 MG CAP?
Since Nov 28, 2013, the NADAC for MORPHINE SULFATE ER 30 MG CAP has ranged from a low of $1.8067 (Oct 23, 2019) to a high of $4.1748 (Jul 15, 2015), with a median of $3.2212 per EA.
Are there cheaper alternatives to MORPHINE SULFATE ER 30 MG CAP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MORPHINE SULFATE ER 30 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures MORPHINE SULFATE ER 30 MG CAP?
MORPHINE SULFATE ER 30 MG CAP (NDC 00832022700) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.